Silo Pharma, Inc. Quarterly Common Stocks, Including Additional Paid in Capital in USD for Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of par value plus amounts in excess of par value or issuance value for common stock issued.
Summary
Silo Pharma, Inc. quarterly Common Stocks, Including Additional Paid in Capital history and growth rate for Q3 2022.
  • Silo Pharma, Inc. Common Stocks, Including Additional Paid in Capital for the quarter ending August 29, 2022 was $135K.
Common Stocks, Including Additional Paid in Capital, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $135K Aug 29, 2022 10-K 2023-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.